Clinical Trial Registration: https://clinicaltrials.gov/ct2/show/NCT03040622.doi:10.1007/s11239-020-02205-5Matthew SherwoodKevin P. BlidenLeonard IlkhanoffGanesh VenkataramanPaul A. GurbelJournal of Thrombosis and Thrombolysis
“It would be nice to see a larger number of patients, as well as a randomized trial of leak closure versus conservative therapy to see what we’re doing. By going after these leaks, are we changing anything? Are we improving their outcomes? Are we minimizing the risk of stroke in ...
Based on the robust Watchman clinical program which consists of numerous studies, with more than 2000 patients and nearly 6000 patient-years of follow-up, the Watchman LAAC Device is the only LAAC device approved by US FDA. Keywords: atrial fibrillation; left atrial appendage closure; Wathcman...